Pharma Pulse 12/5/24: AI-Powered Solutions for Better Patient Adherence, Burnout Plagues Every Level of Pharmacy & more

Personalized AI-Powered Solutions for Better Patient Adherence

In this part of his Pharmaceutical Executive video interview, Bill Grambley, CEO of AllazoHealth, identifies how AI can identify patients at risk of medication non-adherence and intervene early to prevent negative outcomes.

From School to the Workforce, Burnout Plagues Every Level of Pharmacy

Examining challenges in pharmacy school is necessary to solve current problems in the workforce.

Sam Altman Downplays the Dangers of AI and Musk

The chief executive of OpenAI said the technology would boost productivity and rejected worries that his rival mogul could use his political influence to harm competitors.

Cellino Appoints Chris Gemmiti, PhD, as SVP of Therapeutics Development

Cellino Biotech, Inc. closed biomanufacturing for personalized regenerative medicines, announced today the appointment of Chris Gemmiti, PhD, as Senior Vice President of Therapeutics Development. Dr. Gemmiti brings more than 25 years of experience in cell therapy and regenerative medicine, through both industry and academic roles, and extensive expertise as a leader in developing novel therapeutics.

@HDAconnect on LinkedIn

Public-private partnerships are critical in preparedness and response efforts for a flu pandemic. HDA's distributor members work closely with the public sector to ensure routine delivery of medical products during emergencies: https://bit.ly/4iaTjr8 #FluChat

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs